Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
Clinical Informatics Directorate, Metro South Health, Woolloongabba, Queensland, Australia.
Pediatr Pulmonol. 2021 Aug;56(8):2707-2716. doi: 10.1002/ppul.25438. Epub 2021 May 3.
Children with chronic wet cough regularly use the health system, experience considerable variability in care, have reduced quality of life (QoL), and, left untreated, poorer health outcomes. Despite this, little is known about the associated economic burden. This study aimed to quantify the cost of chronic wet cough among Australian children from the perspectives of families and the health system.
A cost of illness study was conducted at the Queensland Children's Hospital, Brisbane, using data on 91 children newly referred to a respiratory specialist between July 2015 and January 2017 with a history of chronic wet cough (>4 weeks) of unknown etiology. Administrative and parent-reported data were used to estimate costs (reported in 2019 Australian Dollars [AUD]) for up to 12 months before and following initial pulmonology consultation. QoL was assessed for the same periods.
Mean cost per child-month during the average 9.8 months of observation preceding pulmonology consultation was AUD689 (95% confidence interval [CI] 534-844) increasing to AUD1339 (95% CI 1051-1628) during the average 11.9 months following pulmonology consultation. This translated to a total of AUD1.9 million across the study period, with families bearing 26.4% of costs. Aspiration and bronchiectasis were associated with higher total costs. For all etiologies, cough-specific QoL improved following pulmonology consultation, while direct medical costs declined.
Childhood chronic wet cough is associated with substantial societal costs. The observed cost decrease after specialist diagnosis suggests that early referral to a respiratory specialist may have economic benefits, in addition to the known health benefits.
患有慢性湿性咳嗽的儿童经常使用医疗系统,护理存在相当大的变异性,生活质量(QoL)降低,如果不进行治疗,健康状况会更差。尽管如此,人们对相关的经济负担知之甚少。本研究旨在从家庭和医疗系统的角度定量评估澳大利亚儿童慢性湿性咳嗽的成本。
在布里斯班昆士兰儿童医院进行了一项疾病成本研究,使用了 2015 年 7 月至 2017 年 1 月期间新转介给呼吸专家的 91 名患有不明病因慢性湿性咳嗽(>4 周)病史的儿童的数据。使用行政和家长报告的数据来估计在初始肺病学咨询之前和之后长达 12 个月的成本(以 2019 年澳元(AUD)报告)。在相同期间评估了 QoL。
在进行肺病学咨询之前的平均 9.8 个月的观察期内,每个孩子每月的平均费用为 689 澳元(95%置信区间 [CI] 534-844),在进行肺病学咨询后的平均 11.9 个月内增加到 1339 澳元(95% CI 1051-1628)。这在整个研究期间共花费了 190 万澳元,家庭承担了 26.4%的费用。吸入和支气管扩张症与总费用较高有关。对于所有病因,肺病学咨询后咳嗽特异性 QoL 有所改善,而直接医疗费用下降。
儿童慢性湿性咳嗽与巨大的社会成本相关。在专家诊断后观察到的成本下降表明,除了已知的健康益处外,早期转介给呼吸专家可能具有经济效益。